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O B J E C T I V E S The current study tested the hypothesis that glucose utilization differs between
visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), and investigated potential
mechanisms for such a ﬁnding.
B A C KG ROUND VAT burden correlates better with cardiovascular risk than does SAT burden.
Beyond volumetric measurement, glucose uptake in adipose tissue (AT) might reﬂect metabolic activity
and provide pathophysiologic insight and aid risk stratiﬁcation.
METHOD S We retrospectively studied tissue-speciﬁc glucose uptake in vivo in clinically obtained
whole-body ﬂuorodeoxyglucose positron emission tomography (FDG-PET) scans in humans. We also
assessed glucose uptake in vitro, using stromal vascular cells isolated from SAT and VAT of diet-induced
obese C57BL/6 mice. Quantitative polymerase chain reaction (PCR) evaluated the expression of multiple
genes involved in cellular glucose metabolism, including glucose transporters (GLUT-1, -3, and -4) and
hexokinases (HK-1 and -2) in SAT and VAT of obese C57BL/6 mice.
R E S U L T S We analyzed whole-body FDG-PET scans from 31 obese and 26 lean patients. VAT
exhibited higher FDG uptake compared with SAT (p  0.0001) independent of age, sex, body mass
index, comorbidities, and medications. To investigate mechanisms underlying this observation, we
studied glucose uptake in the stromal vascular cell fraction of AT, which is rich in inﬂammatory cells.
Stromal vascular cells from VAT of diet-induced obese C57BL/6 mice exhibited higher glucose uptake
than those from SAT (p 0.01). Evaluation of expression of glucose transporters (GLUT-1, -3, and -4) and
hexokinases (HK-1 and -2), revealed increased expression of HK-1 in VAT-derived compared with
SAT-derived stromal vascular cells, and also in visceral versus subcutaneous unfractionated AT.
CONC L U S I O N S In humans in vivo, VAT has increased glucose uptake compared with SAT, as
determined noninvasively with FDG PET imaging. Differential stromal metabolic activity may be 1
mechanism underlying differences in metabolic activity of visceral and subcutaneous AT. (J Am Coll
Cardiol Img 2010;3:843–51) © 2010 by the American College of Cardiology Foundation
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844he dramatic increase in obesity and related
metabolic complications during the last decade
threatens to reverse the progressive decrease in
cardiovascular deaths realized over the last 50
ears (1). Although excess overall adiposity associates
ith cardiovascular morbidity and mortality, the dis-
ribution of body fat across different adipose tissue
See page 852
AT) compartments provides additional important
nformation on risk (2,3). Indeed, whereas the amount of
isceral adipose tissue (VAT) correlates highly with an
dverse risk factor profile (4,5), the amount of subcuta-
eous adipose tissue (SAT) has a less ominous import in
bese individuals (6).
The potential clinical impact of biologic
diversity between fat depots has triggered
intense research to better understand physi-
ologic and molecular differences based on
AT location. Several studies have already
demonstrated differences between VAT and
SAT regarding secretion of inflammatory
mediators, gene expression, and cell mor-
phology. Yet glucose utilization between
these 2 adipose compartments remains in-
completely understood (7–10). A recent
study shows that AT glucose uptake deter-
mined by fluorodeoxyglucose positron emis-
sion tomography (FDG-PET) may comple-
ment volumetric measurements of fat for the
purpose of risk estimation (11).
This study demonstrates higher FDG
uptake in VAT compared with SAT in
humans using the FDG-PET imaging
technique, and investigates potential mo-
lecular mechanisms mediating this effect.
E T H O D S
uman subjects and FDG-PET imaging. The institu-
ional review board of Brigham and Women’s
ospital approved the human studies. We retro-
pectively analyzed 31 obese patients and 26 lean
atients who underwent whole-body PET-
omputed tomography (CT) scanning for diagnosis
r staging of primary lung cancer with respect to the
ntensity of FDG uptake in abdominal visceral and
ubcutaneous AT. Individuals exhibiting abnormal
DG uptake in the abdominal region suspicious for
etastases, and 2 individuals with fat standard
ptake values (SUVs) that were 8 and 18 standard
rase
e
e
eeviations above the mean, were excluded from Inalysis. After fasting for 4 to 6 h, the patients
eceived FDG (777  111 MBq, 21  3 mCi)
ntravenously, and whole-body images were ac-
uired on a Discovery ST PET/CT scanner (Gen-
ral Electric, Milwaukee, Wisconsin), 83  22 min
fter tracer administration as described previously
12). Briefly, a noncontrast CT scan was performed
rst for attenuation correction and localization.
mmediately after the CT scan, the PET scan was
cquired in 2-dimensional mode at 6 to 7 bed
ositions (4 min for each position). PET data were
econstructed using an ordered-subset expectation
aximization iterative algorithm.
Hermes Gold 2.1 software (Hermes Medical
olutions, Stockholm, Sweden) was used for image
nalysis (Fig. 1). We first created a “fat mask” of the
riginal CT image set by removing pixels with
ensities below 110 HU or above 70 HU, a
ange corresponding to AT densities in human
ubjects (13). We then divided the obtained CT fat
ask by itself to acquire a binary CT fat mask in
hich pixels had the value of 1 in AT and 0 in all
ther tissues. We further resampled the original
ET file to match the slice thickness and matrix
ize of the CT file, and multiplied the resampled
ET image set by the binary CT fat mask. This
peration left only those pixels in the PET image
et that corresponded to the pixels with the value of
in the CT fat mask. We converted this PET
mage set into the original matrix size and pro-
eeded with the analysis as follows. We drew
egions of interest in visceral and subcutaneous AT
n 15 to 25 consecutive slices to create a volume of
nterest (VOI). We recorded tracer activity (bec-
uerels per cubic centimeter) in each pixel display-
ng a value above 0, and converted this number to
he SUV using a standard formula accounting for
ixel activity (becquerels per cubic centimeter),
atient weight (kilograms), and injected dose (bec-
uerels), decay corrected to the time of injection.
e then averaged SUVs from each pixel in a VOI
o obtain a single SUV for a given VOI in both
AT and VAT regions.
xperimental animals and isolation of stromal vascular
ells. C57BL/6 mice were obtained from the Jack-
on Laboratory (Bar Harbor, Maine) and kept at a
arrier animal facility of the Harvard Medical
chool. All experiments conformed to animal care
rotocols approved by the institutional review
oard. Mice were fed a high-fat diet (PicoLab
odent Chow D12108, containing 40% kcal from
at, 1.25% cholesterol, 0% cholate; Research Diets,B B R E V I A T I O N S
N D A C R O N YM S
T adipose tissue
MI bodymass index
T computed tomography
DG fluorodeoxyglucose
LUT glucose transporter
K hexokinase
ET positron emission
omography
PCR quantitative polyme
hain reaction
AT subcutaneous adipos
issue
UV standard uptake valu
VC stromal vascular cell
AT visceral adipose tissunc., New Brunswick, New Jersey). At sacrifice, we
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845erfused animals with normal saline to remove
lood cells from the vascular system and dissected
bdominal subcutaneous and periepididymal vis-
eral fat pads.
To isolate stromal vascular cells (SVCs), we
inced the fat pads in phosphate-buffered saline
PBS) containing 2% bovine serum albumin and
50 U/ml of collagenase II (Worthington Bio-
hemical Corporation, Lakewood, New Jersey), and
ncubated it at 37°C for 1 h. We passed the digested
issue through a 70-m nylon cell strainer (BD
iosciences, San Jose, California) and centrifuged
he flow-through. After removing the supernatant,
e lysed red blood cells with ACK lysis buffer
Gibco, Carlsbad, California) and washed and
ounted the remaining cells, which we then used for
ell culture or RNA isolation, as described in the
ollowing text.
ytokines and chemicals. Murine cytokines were ob-
ained from Peprotech (Rocky Hill, New Jersey)
nd tested by the manufacturer for the absence of
ipopolysaccharide (LPS). We prepared all cytokine
tock solutions in LPS-free sterile PBS and diluted
he working solutions with culture medium before
timulation. Specific biological activities of cyto-
ines were 1 107 U/mg for IFN-gamma, 1 107
/mg for TNF-alpha, and 5  108 U/mg for
L-1beta. We describe cytokine concentrations in
ections detailing cell stimulations. We purchased
-deoxy-D-glucose (2dG) and cytochalasin B from
igma (St. Louis, Missouri), and 3H-2dG from
erkinElmer (Waltham, Maine).
lucose uptake assay. Cultured SVCs were incu-
ated in KRH buffer (136 mmol/l NaCl, 4.7
mol/l KCl, 1.25 mmol/l MgSO4, 1.25 mmol/l
aCl2, 50 mmol/l HEPES) for 30 min at 37°C to
eplete endogenous glucose stores. Next, we added
H-2dG and unlabeled 2dG to the cells (final
oncentration, 100 mol/l for each, and specific
ctivity of 0.5 Ci/sample for 3H-2dG) with or
ithout the inhibitor cytochalasin B (final concen-
ration 10 mol/l) to determine carrier-nonspecific
ptake (14). We incubated cells for 5 min at room
emperature, after which we removed the incuba-
ion buffer and washed the cells twice with 25
mol/l ice-cold unlabeled D-glucose to stop uptake
f radiolabeled glucose via saturation of transport-
rs. We lysed cells with 1% Triton X-100 (Sigma).
e used lysates for liquid scintillation counting
Beckman LS 6000IC counter) and protein mea-
urements using BCA assay (Pierce, Rockford,
llinois). The net uptake of 3H-2dG by cells is
ormalized to protein content and expressed as Uanomoles of glucose per milligram of protein per
inute. We analyzed each sample in duplicate, and
he values were averaged. The data presented on the
raphs and in the tables represent mean  SEM of
ata obtained on cells from several experiments (n for
ach experiment is indicated in the respective figure
egend). All graphs show GLUT-mediated glucose
ptake (total uptake minus cytochalasin B-inhibited
ptake).
ell culture and stimulations. After isolation, we cul-
ured murine SVCs in RPMI-1640 medium sup-
lemented with 10% fetal calf serum (FCS), 100
Figure 1. Flow Chart of FDG-PET/CT Image Analysis
(1) We created a binary “fat mask” of the computed tomography (C
by removing pixels with densities below 110 HU or above 70 H
resampled the positron emission tomography (PET) image to match sl
ness and the matrix size of the CT image. (2) We then multiplied the f
masked CT image and resampled PET image to create a fat mask of th
image. (3) We drew regions of interest on several slices and combin
to obtain a volume of interest (VOI). (4) We recorded tracer activity
rels per cubic centimeter) in each pixel and converted it to the stan
uptake value (SUV). (5) We discarded 0 values and averaged all pos
ues to obtain an average SUV for the VOI. FDG  ﬂuorodeoxyglucoT) image
U. We
ice thick-
at-
e PET
ed them
(becque-
dard
itive val-/ml penicillin, 100 g/ml streptomycin, and 2
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846mol L-glutamine. We plated cells on 24-well plates
t a density of 250,000 cells/well and allowed them to
dhere for 24 h, after which we stimulated them with
mixture of murine TNF-alpha and IL-1beta (10
g/ml each). We then performed glucose uptake in
ultured cells at baseline and at 24 and 48 h after
timulation.
NA isolation and analysis of gene expression. RNA
solation from the SVCs was performed using RNeasy
ini spin columns (Qiagen, Germantown, Mary-
and), according to the manufacturer’s instructions.
e carried out RNA isolation from whole AT with
Neasy Lipid Tissue Midi Kit (Qiagen), according to
he manufacturer’s instructions. We assessed RNA
oncentration and purity using Nanodrop 1000 UV
pectrophotometer (Thermo Scientific, Wilmington,
elaware). One microgram of RNA was reverse
ranscribed into complementary DNA (cDNA) using
uperscript II reverse transcriptase (Invitrogen, Carls-
ad, California) and oligo-dT primers (Invitrogen).
We performed quantitative polymerase chain re-
ction (qPCR) on 2 l of cDNA with the MyiQ
eal-Time PCR Detection System (BioRad, Her-
ules, California) using the primer sequences indi-
ated in Table 1. We calculated relative expression
atios of genes in visceral fat compared with subcu-
aneous fat using the Cq method with GAPDH
RNA expression as reference. Further details on
NA isolation and qPCR can be found in the
nline Methods supplement to the article.
tatistical analysis. We performed statistical analysis
ith the GraphPad Prism version 4.0 (GraphPad
oftware, La Jolla, California), StatView 5.0.1
SAS Institute, Cary, North Carolina), and SAS
ersion 9.1 (SAS Institute) software packages. De-
criptive summaries included means, standard devi-
tions, and percentages. The obese and lean cohorts
ere compared in terms of patient characteristics
nd fat SUV using the chi-square or Wilcoxon rank
um test. The within-subject analysis of VAT
ompared with SAT was a mixed models analysis of
Table 1. Sequences of Primers Used for RNA Ampliﬁcation
Gene Name (GeneBank Accession #) Forw
GLUT-1 (NM_011400.3) 5’-ATGGATCC
GLUT-3 (NM_011401.3) 5’-GGTGGCTG
GLUT-4 (NM_009204.2) 5’-GACGGACA
HK-1 (NM_010438.2) 5’-GCGAGGAC
HK-2 (NM_013820.3) 5’-CAACTCCG
GAPDH (XM_001473623.1) 5’-TGGGTGTG
GAPDH  glyceraldehyde-3-phosphate dehydrogenase; GLUT  glucose transpariance, with patient as a random effect and fixedffects of fat depot (SAT or VAT) and cohort
obese or lean). Potential confounding variables
ere added to the model individually, with each
odel having 3 fixed effects. Reliability of VAT and
AT SUV values in a subset of 8 obese and 8 lean
atients was assessed by the Pearson correlation
oefficient between the first and second repeated
easures, the 95% confidence interval around the
ean difference, and the intraclass correlation co-
fficient with 95% confidence interval. Statistical
nalysis on graphs 2 and 4 was performed using the
ann-Whitney U test, and the Wilcoxon signed
ank test was used on graph 3. Nominal p values
ere reported, unadjusted for multiple testing.
E S U L T S
e assessed FDG-PET scans from 31 obese (body
ass index [BMI] 30 kg/m2) and 26 lean (BMI
25 kg/m2) subjects. Table 2 provides patient
Primer Reverse Primer
CAGCAAG-3’ 5’-CCAGTGTTATAGCCGAACTGC-3’
GTTGTAACT-3’ 5’-GCAGCGAAGATGATAAAAACG-3’
CATCTGTTG-3’ 5’-GCCACGATGGAGACATAGC-3’
GCTGTAGATG-3’ 5’-CCGCATGGCATACAGATACTT-3’
GGGACAG-3’ 5’-CACACGGAAGTTGGTTCCTC-3’
CATGAGAAG-3’ 5’-GCTAAGCAGTTGGTGGTGC-3’
r; HK  hexokinase.
Table 2. Baseline Characteristics of Patients
Lean
Patients
(n  26)
Obese
Patients
(n  31) p Value
Females 14 (54) 15 (48) 0.68
Age (yrs) 66.0 14.8 61.4 10.4 0.08
BMI (kg/m2) 21.7 0.6 36.4 3.5 0.001
Hypertension or
antihypertensive drug
9 (35) 20 (65) 0.02
Diabetes 2 (8) 8 (26) 0.07
Smoking 15 (58) 14 (45) 0.35
CAD 2 (8) 7 (23) 0.12
Diuretic 3 (12) 8 (26) 0.17
Beta-blocker 5 (19) 9 (29) 0.39
Statin 2 (8) 7 (23) 0.12
Ca2 blocker 1 (4) 5 (16) 0.13
ACE inhibitor 3 (12) 6 (19) 0.42
NSAID 6 (23) 7 (23) 0.96
Any drug 9 (35) 17 (55) 0.13
Values are n (%) or mean  SD.
ACE  angiotensin-converting enzyme; BMI  body mass index; CAD ard
CAG
GCT
CTC
AG
GAT
AACcoronary artery disease; NSAID  nonsteroidal anti-inﬂammatory drug.
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847haracteristics. There were significantly more obese
atients with hypertension or on blood pressure
edications, as compared with lean patients (65%
s. 35%, p  0.02). The cohorts did not differ
ignificantly in other patient characteristics.
isceral fat in humans exhibits higher FDG uptake than
ubcutaneous fat. Analysis of FDG-PET/CT scans
rom patients revealed that lean and obese cohorts
id not differ significantly with respect to subcuta-
eous FDG uptake (0.30  0.09 vs. 0.33  0.08,
 0.18) or visceral FDG uptake (0.88  0.18
s. 0.81  0.23, p  0.15). Visceral fat showed
ignificantly higher FDG uptake than subcutaneous
bdominal AT in both the lean (BMI 25 kg/m2)
p  0.0001) and obese (BMI 30 kg/m2) subjects
p  0.0001) (Fig. 2). Potentially important covari-
tes, such as age, sex, diabetes, a history of coronary
rtery disease, hypertension or use of antihyperten-
ive therapy, and smoking history, did not affect this
ifference in FDG signal associated with fat depots.
DG uptake in SAT and VAT in men and women
verall and within both lean and obese groups is
hown in Online Figure 1. Medications (statins,
iuretics, beta-adrenergic blockers, Ca2-channel
lockers, angiotensin-converting enzyme inhibitors,
nd aspirin, or a combination of drugs) also did not
lter results.
To investigate the reliability of the measurement,
he assessment of FDG uptake was repeated in 8
bese and 8 lean patients. Table 3 shows mean
ifferences and 95% confidence intervals around the
ean differences, along with correlations and intra-
lass correlation coefficients. The measurements
ere most reliable for subcutaneous fat, with a
orrelation of 0.88 (p  0.0001) and an intraclass
orrelation coefficient of 0.87 (95% confidence in-
erval: 0.68 to 0.95).
To probe the mechanisms contributing to higher
DG uptake in visceral than in subcutaneous AT,
e conducted a series of ex vivo and in vitro
xperiments on cells obtained from mouse AT.
-Deoxy-glucose uptake is higher in mouse SVCs from
isceral fat compared with subcutaneous fat. We first
solated SVCs from subcutaneous and visceral fat
epots from mice with diet-induced obesity and
easured glucose uptake in these cells. Baseline
lucose uptake, normalized for protein content, was
igher in SVCs from VAT compared with those
rom SAT (Fig. 3A). Interestingly, there were no
pparent differences in the rate of glucose uptake in
nimals of different ages (data not shown). These
ndings corroborated our PET data in humans.
VCs from visceral fat also tended to show higherlucose uptake at 24 and 48 h after plating (Fig.
A). TNF-alpha and IL-1beta, both important
ytokines involved in AT inflammation, boosted
lucose uptake in visceral and subcutaneous SVCs
Fig. 3B).
xpression of glucose metabolism-related genes in
ouse AT. To examine further mechanisms that
ight increase glucose uptake in visceral fat, we
tudied the expression of glucose metabolism-
elated genes in mouse SVCs and unfractionated
T. We performed real-time PCR analysis for the
xpression of GLUT-1, -3, and -4, as well as HK-1
nd 2, in SVCs isolated from SAT and VAT and in
nfractionated AT from both depots. SVCs from
AT exhibited significantly higher expression of
K-1 compared with SVCs from SAT (Fig. 4A).
his difference was observed in SVCs when data
G
lu
co
se
 U
pt
ak
e 
(S
UV
)
SAT VAT SAT VA
Lean Obese
0.75
1.5 * *
Figure 2. FDG Uptake in Human SAT and VAT
Average intensity of ﬂuorodeoxyglucose (FDG) uptake (in standard
value [SUV]) in subcutaneous adipose tissue (SAT) and visceral adip
sue (VAT) in lean patients (body mass index [BMI] between 21 and
kg/m2) and obese patients (BMI between 32.8 and 45.3 kg/m2). The
zontal line in the box plots represents the median value; the boxe
the interquartile range, and the whiskers denote the 10th and 90th
tiles. *p  0.05.
Table 3. Evaluation of Reliability in Measurement of FDG Uptak
Group Mean Difference (95% CI) Correlation
Subcutaneous
Overall 0.001 (0.018, 0.019) 0.88, p 0.0001
Lean 0.010 (0.018, 0.039) 0.93, p 0.001
Obese 0.009 (0.038, 0.021) 0.67, p 0.07
Visceral
Overall 0.065 (0.15, 0.021) 0.60, p 0.01
Lean 0.028 (0.158, 0.102) 0.56, p 0.15
Obese 0.102 (0.242, 0.039) 0.70, p 0.05T
uptake
ose tis-
22.7
hori-
d area is
percen-e
ICC (95% CI)
0.87 (0.68, 0.95)
0.92 (0.72, 0.98)
0.67 (0.09, 0.91)
0.56 (0.13, 0.81)
0.59 (0.04, 0.88)
0.53 (0.13, 0.86)CI  conﬁdence interval; FDG  ﬂuorodeoxyglucose; ICC  intraclass correlation coefﬁcient.
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848ere pooled from both 8-week-old and 16-week-
ld mice (Fig. 4) or analyzed separately at each age
data not shown). Levels of mRNAs encoding
LUT-1, -3, and -4 were lower in SVCs from
isceral fat compared with SVCs from subcutaneous
at, but these differences were of much lesser mag-
itude than that of HK-1 induction (Fig. 4A).
eal-time PCR on whole-fat samples from mice
lso revealed increased HK-1 expression in visceral
ompared with subcutaneous AT (Fig. 4B).
I S C U S S I O N
hysiologic differences between AT compartments
n the body, particularly between subcutaneous and
isceral depots, have long attracted attention. VAT
urden portends higher cardiometabolic risk (4,5),
hereas an increased amount of SAT shows the
pposite association in obese individuals (6). Bio-
ogically, the 2 adipose depots also differ in the
pectrum of inflammatory mediators they secrete.
This study tested the hypothesis that noninvasive
unctional imaging could reveal metabolic differ-
nces between AT depots in intact humans. Most
linical studies to date have used volumetric quan-
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Figure 3. Glucose Uptake in SAT- and VAT-Derived SVCs
(A) Rate of glucose uptake in stromal vascular cells (SVCs) isolated
adipose tissue (VAT) (green bars). Glucose uptake is shown at base
 SEM of 3 to 7 measurements. (B) Rate of glucose uptake in SVCs
tory cytokines TNF- and IL-1 for 24 and 48 h. Data are shown as
subcutaneous depot were pooled from 2 to 3 animals. *p  0.05.ification of AT depots by CT or magnetic reso- aance imaging. A recent preliminary report, how-
ver, suggested that volumetric measurements alone
ay not be sufficient and could be improved with a
unctional readout of the metabolic activity in a fat
ompartment by means of PET (11). This report,
owever, did not investigate whether PET can
etect differences between VAT and SAT compart-
ents.
We show that VAT exhibits higher FDG uptake
ompared with SAT in humans in vivo. This
ifference remains significant after adjustment for
otentially confounding covariates (age, sex, BMI,
oncomitant medications, or comorbidities includ-
ng established diabetes, coronary artery disease, or
ypertension) in the multivariate analysis. Thus,
AT displays higher metabolic activity than SAT,
s assessed noninvasively in humans. Our results
gree with earlier studies by Virtanen et al. (9,10),
hich showed higher rates of glucose uptake in VAT
ompared with SAT in groups of healthy and diabetic
en under euglycemic hyperinsulinemic conditions.
lthough well designed, these studies enrolled only
ales with or without diabetes and did not assess basal
ates of glucose uptake (9), which might limit the
SVCs from SAT at baseline
SVCs from VAT at baseline
SVCs from SAT after TNF + IL-1
SVCs from VAT after TNF + IL-1
mouse subcutaneous adipose tissue (SAT) (red bars) and visceral
(0 h) and after 24 and 48 h of culture. Data are shown as mean
SAT (red bars) and VAT (green bars) stimulated with inﬂamma-
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849tudy complements these results by assessing basal
ates of glucose uptake in a heterogeneous group of
ubjects including both sexes, with or without comor-
idities. Taken together, these results suggest that
DG-PET could enable noninvasive functional in
ivo analysis of AT metabolic activity.
The clinical findings prompted a search for pos-
ible causes of different metabolic activity in SAT
nd VAT. In light of previous studies showing the
resence of inflammatory cells in AT (15,16), we
ypothesized that these cells may contribute to
ifferential glucose uptake in VAT and SAT. SVCs
erived from AT contain inflammatory cells such as
acrophages and T cells. Indeed, VAT-derived
VCs isolated from diet-induced obese C57BL/6
ice exhibited significantly higher absolute rates of
lucose uptake than those from SAT. We normal-
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Figure 4. Expression of Glucose Metabolism-Related Genes in S
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and normalized to housekeeping gene expression (GAPDH). Data ar
HK  hexokinase.zed glucose uptake values for protein concentra- Aion, which suggests increased rates of glucose
ptake per cell of VAT rather than an increase due
o greater cellularity in VAT. These findings indi-
ate that not only increased cellularity, but also
reater glucose uptake in each cell, contributes to
he higher glucose uptake detected in vivo in human
AT compared with SAT.
Finally, to identify molecular mechanisms under-
ying differential glucose uptake in VAT and SAT,
e assessed the expression of genes involved in the
ransport and phosphorylation of glucose. GLUTs
ediate cellular uptake of this sugar (17). Upon
ntering the cell, glucose undergoes phosphoryla-
ion by hexokinase (HK), which exists in 2 main
soforms (HK-1 and HK-2) exhibiting different
issue localization (18). VAT-derived SVCs show
igher HK-1 expression than SAT-derived SVCs.
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8504 was lower in VAT-derived SVCs, but exhibited
uch smaller differences between SAT- and VAT-
erived SVCs, which raises questions regarding
heir biological contribution to the differences ob-
erved in glucose uptake. Moreover, HK-1 expres-
ion was also higher in unfractionated VAT com-
ared with SAT, whereas GLUT-1, -3, and -4 and
K-2 expression levels did not differ. This suggests
hat the reduced expression of GLUT-1, -3, and -4
nd HK-2 in SVCs within the VAT may be
ompensated by their higher level of expression in
on-SVCs in the same fat pad. Therefore, the
ncrease in HK-1 expression may be sufficient to
ncrease glucose uptake in VAT and likely results
rom accentuated differences in expression in the
VCs. Perrini et al. (8) likewise showed that
LUT-1 and -4 expression did not differ between
AT and SAT SVC-derived adipocytes. These
bservations suggest that an increase in HK-1
xpression may be sufficient to increase glucose
ptake in VAT, as detected noninvasively by FDG-
ET. Additional studies are nevertheless necessary
o draw definitive conclusions.
Despite the association of obesity with inflamma-
ion, this study found no difference in FDG uptake in
AT between obese and lean individuals. We conjec-
ure that even though SVCs in VAT from obese
ndividuals contain more inflammatory cells, which
ould augment glucose uptake in VAT from obese
ubjects, their contribution to overall glucose uptake in
uch individuals may be counterbalanced by the
reater mass of presumably insulin-resistant adipo-
ytes, the most abundant cell type within this tissue.
tudy limitations. We quantified FDG uptake in
T using SUVs, a clinically accepted way of ana-
yzing PET studies. Nonetheless, SUVs may have
ntersubject and intrasubject variability as a result of
ultiple factors, including plasma glucose and in-
ulin concentrations and the time of image acqui-
ition after FDG injection. Moreover, quantifica-
ion of FDG uptake requires 4-compartmentCE. Mechanisms linking obesity with Investigation Into Cerformed in our study, and therefore, our measure-
ents are semiquantitative in nature.
O N C L U S I O N S
e demonstrated significant differences in meta-
olic activity between SAT and VAT in humans
sing a standard noninvasive FDG-PET technique.
nvestigating mechanisms underlying this observa-
ion, we found increased glucose uptake in SVCs
rom VAT compared with SVCs from SAT in
iet-induced obese mice. Further, we showed that
he increase in glucose uptake in VAT may arise, in
art, to increased expression of HK-1 in VAT-
erived SVCs. These results affirm that different fat
epots associated with distinct clinical outcomes
xhibit differential metabolic activity in situ in
ntact humans.
Visceral adiposity has become a therapeutic tar-
et for numerous novel pharmacologic and other
trategies aimed at the improvement of dysmetabo-
ism. Although plasma biomarkers provide 1 win-
ow on efficacy, availability of an imaging modality
o directly probe the target tissue would help drug
evelopment programs evaluate efficacy and per-
orm better dose selection in clinical trials. These
xamples illustrate potential practical applications
or the use of imaging adipose tissue metabolic
ctivity.
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